TORONTO, Feb. 07, 2022 (GLOBE NEWSWIRE) — Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the “Company”), a life science biotechnology company pioneering the use of natural psychedelics in mental health and well-being, is pleased to announce that its ISO22000 graded Psilocybin production facility has officially received International Organization for Standardization (ISO) 22000:2018…


Previous articlePsychedelic Research Bulletin: January 2022
Next articlePT291 – Rick Tarnas & Sean Kelly, Ph.D. – The Impact of Stanislav Grof, Ego Death, and The Psyche Unbound